Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoxia and Hypoxia-Inducible Factors in Kidney Injury and Repair
Shaoqun Shu, Ying Wang, Meiling Zheng, et al.
Cells (2019) Vol. 8, Iss. 3, pp. 207-207
Open Access | Times Cited: 225

Showing 1-25 of 225 citing articles:

Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis
Xinhui Wang, Xuexian Fang, Zhaoxian Cai, et al.
Research (2020) Vol. 2020
Open Access | Times Cited: 385
ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury
Yue Wang, Menghan Zhang, Ran Bi, et al.
Redox Biology (2022) Vol. 51, pp. 102262-102262
Open Access | Times Cited: 273
Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection
Holger Scholz, Felix Boivin, Kai M. Schmidt‐Ott, et al.
Nature Reviews Nephrology (2021) Vol. 17, Iss. 5, pp. 335-349
Closed Access | Times Cited: 214
Hypoxia and HIF Signaling: One Axis with Divergent Effects
Chiara Corrado, Simona Fontana
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5611-5611
Open Access | Times Cited: 146
Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming
Zijing Zhu, Jijia Hu, Zhaowei Chen, et al.
Metabolism (2022) Vol. 131, pp. 155194-155194
Closed Access | Times Cited: 99
Obesity-related kidney disease: Beyond hypertension and insulin-resistance
Tarek Ziad Arabi, Areez Shafqat, Belal Nedal Sabbah, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 47
The role of oxidative stress and hypoxia in renal disease
Tomoko Honda, Yosuke Hirakawa, Masaomi Nangaku
Kidney Research and Clinical Practice (2019) Vol. 38, Iss. 4, pp. 414-426
Open Access | Times Cited: 137
Deciphering the Pharmacological Mechanisms of Taohe-Chengqi Decoction Extract Against Renal Fibrosis Through Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
Shanshan Zhou, Zhongzhu Ai, Weinan Li, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 72
Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation
Ewa Wojtaszek, Urszula Ołdakowska‐Jedynak, Marlena Kwiatkowska, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 63
New insights into crosstalk between apoptosis and necroptosis co-induced by chlorothalonil and imidacloprid in Ctenopharyngodon idellus kidney cells
Xiaojing Li, Xia Zhao, Yujie Yao, et al.
The Science of The Total Environment (2021) Vol. 780, pp. 146591-146591
Closed Access | Times Cited: 56
Mitochondria bridge HIF signaling and ferroptosis blockage in acute kidney injury
Wenju Li, Zhidan Xiang, Yuexian Xing, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 47
The Interplay between Immune and Metabolic Pathways in Kidney Disease
Lili Qu, Baihai Jiao
Cells (2023) Vol. 12, Iss. 12, pp. 1584-1584
Open Access | Times Cited: 30
Pathway from Acute Kidney Injury to Chronic Kidney Disease: Molecules Involved in Renal Fibrosis
Andrei Niculae, Mihai-Emil Gherghina, Ileana Peride, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14019-14019
Open Access | Times Cited: 29
Mitochondria-mediated Ferroptosis in Diseases Therapy: From Molecular Mechanisms to Implications
Fuhai Feng, Shasha He, Xiaoling Li, et al.
Aging and Disease (2023) Vol. 15, Iss. 2, pp. 714-714
Open Access | Times Cited: 27
Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities
Francesco Patera, Leonardo Gatticchi, Barbara Cellini, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 137-137
Open Access | Times Cited: 15
The role of epithelial cells in fibrosis: Mechanisms and treatment
Liuyi Luo, Wei Zhang, Siyao You, et al.
Pharmacological Research (2024) Vol. 202, pp. 107144-107144
Open Access | Times Cited: 10
Modulating HIF-1α/HIF-2α Homeostasis with Shen-Qi-Huo-Xue Formula alleviates Tubular Ferroptosis and Epithelial-Mesenchymal Transition in Diabetic Kidney Disease
Ronglu Yang, Wu Liu, Yi Zhou, et al.
Journal of Ethnopharmacology (2025), pp. 119478-119478
Closed Access | Times Cited: 1
Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis
Deepika Watts, Diana Gaete, Diego A. Rodríguez, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8131-8131
Open Access | Times Cited: 50
Urinary EGF and MCP-1 and risk of CKD after cardiac surgery
Steven Menez, Wenjun Ju, Rajasree Menon, et al.
JCI Insight (2021)
Open Access | Times Cited: 43
Tubular Cell Glucose Metabolism Shift During Acute and Chronic Injuries
Anna Faivre, Thomas Verissimo, Hannah Auwerx, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 43
Sirtuins and Renal Oxidative Stress
Yoshio Ogura, Munehiro Kitada, Daisuke Koya
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1198-1198
Open Access | Times Cited: 41
Therapies Targeting Epigenetic Alterations in Acute Kidney Injury-to-Chronic Kidney Disease Transition
Fumiaki Tanemoto, Imari Mimura
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 123-123
Open Access | Times Cited: 33
Driving role of macrophages in transition from acute kidney injury to chronic kidney disease
Xiao‐Ming Meng, Juan Jin, Hui Y. Lan
Chinese Medical Journal (2022) Vol. 135, Iss. 7, pp. 757-766
Open Access | Times Cited: 30
Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors
Francesco Locatelli, Roberto Minutolo, Luca De Nicola, et al.
Drugs (2022) Vol. 82, Iss. 16, pp. 1565-1589
Open Access | Times Cited: 30
Recent Update on Acute Kidney Injury-to-Chronic Kidney Disease Transition
Eun Sil Koh, Sungjin Chung
Yonsei Medical Journal (2024) Vol. 65, Iss. 5, pp. 247-247
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top